CAS: 1435-55-8; (S)-((1S,2R,4S,5R)-5-Ethylquinuclidin-2-yl)(6-Methoxyquinolin-4-yl)Methanol

该化合物是一种化学化合物,属于五碘衍生物类别,主要以其用于治疗某些心心律不全而闻名;它是具有抗心律特性的碱性,作为钠管阻塞器发挥作用,有助于稳定心脏膜膜,恢复正常的心脏节奏;氢丙胺通常以晶体形式出现,以其特定的分子结构为特征,其中包括一个双循环系统;该化合物在水中溶解,呈现中性亲脂性,使其能与生物膜有效互动;其药理学特征包括潜在的副作用,如胃肠紊乱和心血管影响,在治疗期间需要仔细监测;氢丙胺经常在受控制的临床环境中施用,其功效和安全通过严格的临床试验得到评估;与许多药物一样,在向病人开用氢丙胺药时,必须考虑药物的相互作用和反作用.

结构式图片

相似化合物

522-66-7 522-66-7 5962-19-6

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号56-54-2 奎尼丁 | CAS号612-11-3 3,4-二乙吡啶 | CAS号41037-26-7 6-甲氧基-4-甲基喹啉水合物 | CAS号86-68-0 6-甲氧基喹啉-4-甲酸 | CAS号113162-02-0 O-(4-氯苯甲酰)氢奎并啶 | CAS号140853-10-7 氢化奎宁 1,4-(2,3-二... | CAS号135042-89-6 氢化奎尼定 4-甲基-2-喹啉甲醚

合成工艺路线路线简述

    Alkaline Earth Salt Of/the/ Methylsulfuric Acid置于sodium Ethanolate,氢化铝体系中,化学反应生成氢化奎尼定
    参考文献:Rabe,Justus Liebigs Annalen Der Chemie,1932,Vol. 492,P. 242,255
    标题:Rabe,Justus Liebigs Annalen Der Chemie,1932,Vol. 492,P. 242,255

    海关参考信息

    专利信息


    专利号:US-9126995-B2
    优先权日:2011-11-08
    标题:Method for catalytic asymmetric synthesis of optically active isoxazoline compound and optically active isoxazoline compound
    发明人:TOYAMA KEN-ICHI; MORIYAMA YUJI; MATOBA KAZUTAKA; YAOSAKA MANABU; IKEDA EITATSU
    权利人:NISSAN CHEMICAL IND LTD
    摘要:There is provided a method for catalytic asymmetric synthesis of optically active isoxazoline compound and an optically active isoxazoline compound. A method for catalytic asymmetric synthesis of optically active isoxazoline compound of a formula (6) including reacting an α,β-unsaturated carbonyl compound of a formula (1) and a hydroxylamine in a solvent in the presence of a base by adding a chiral phase transfer catalyst. An optically active isoxazoline compound of a formula (13) that can be synthesized by the method.

    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:US-7173059-B2
    优先权日:2003-05-08
    标题:Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same
    发明人:ALBIZATI KIM FRANCIS; BABU SRINIVASAN
    权利人:AGOURON PHARMA
    摘要:Optically active 3-amino-butene and 1,2-dihydroxy-3-amino-butane intermediate compounds, useful in the synthesis of HIV-protease inhibitors and methods of preparing these intermediate compounds are disclosed.

    专利号:US-6700001-B2
    优先权日:2001-10-05
    标 题:Process for stereoselective synthesis of 2-hydroxymethyl chromans
    发明人:GROSS JONATHAN L; STACK GARY P
    权利人:WYETH CORP
    摘要:A process for the stereoselective synthesis of 2-hydroxymethyl-chromans of formula (II) is providedwhere R, R<1>, R<2 >and R<3 >are as defined herein. The compound of formula (II) is prepared using an optically active benzene compound of formula (I)where R<0 >is as defined herein. The 2-hydroxymethyl-chroman compounds of formula (II) are useful as intermediates for preparing a variety of medicinal agents.

    专利号:US-5434152-A
    优先权日:1993-11-08
    标题:Asymmetric synthesis of (S)-(-)-6-chloro-4- cyclopropyl-3,4-dihydro-4-[(2-pyridyl)ethynyl]-2(1H)-quinazolinone
    发明人:HUFFMAN MARK A; YASUDA NOBUYOSHI; DECAMP ANN E; GRABOWSKI EDWARD J J
    权利人:MERCK & CO INC
    摘要:An asymmetric synthesis of (S)-(-)-6-chloro-4-cyclopropyl-3,4-dihydro-4-[(2-pyridyl)ethynyl]-2(1H)-quinazolinone comprises the chiral addition of 2-pyridylacetylide to N 1 -protected 6-chloro-4-cyclopropyl-2-quinazolinone followed by removal of the protecting group.

    专利号:US-9505733-B2
    优先权日:2011-11-18
    标题:Single step enantioselective process for the preparation of 3-substituted chiral phthalides
    发明人:REDDY REKULA SANTOSH; NAGA CHITHANYA KIRAN INDUKURU; ARUMUGAM SUDALAI
    权利人:COUNCIL SCIENT IND RES
    摘要:The present invention discloses single step, highly enantioselective catalytic oxidative cyclization process for the synthesis of 3-substituted chiral phthalides. In particular, the invention discloses asymmetric synthesis of chiral phthalides via synergetic nitrile accelerated oxidative cyclization of o-cyano substituted aryl alkenes in high yield and enantiomeric excess (ee) in short reaction time. Also, disclosed herein is “one-potâ€? asymmetric synthesis of biologically important natural compounds having 3-substituted chiral phthalide structural framework in the molecule.
    苏州润森药物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.rosen-chemicals.com
    企业联系电话:17712495068👤
    📞苏州润森药物科技有限公司 ⚠️参考联系方式
    联系人:杨总
    电话:17712495068
    手机:18751140360
    传真:QQ:640192082
    邮箱:sales@rosen-chemicals.com
    通信地址: 江苏省苏州高新区新亭路5号1幢2楼
    邮编: 235300
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省苏州高新区新亭路5号1幢2楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Chimienti M, Et, Al. Comparison Of The Effectiveness Of Dihydroquinidine And Quinidine On Ventricular Ectopy After Acute And Chronic Administration. Cardiovasc Drugs Ther. 1988 Dec;2(5):679-86.
    [参考文献]: Hermida Js, Et, Al. Hydroquinidine Therapy In Brugada Syndrome. J Am Coll Cardiol. 2004 May 19;43(10):1853-60.
    [参考文献]: Mazzanti A, Et, Al. Hydroquinidine Prevents Life-Threatening Arrhythmic Events In Patients With Short Qt Syndrome. J Am Coll Cardiol. 2017 Dec 19;70(24):3010-3015.
    [参考文献]: Chen Zhang, Et Al. Macromolecular Crowding-Assisted Fabrication Of Liquid-Crystalline Imprinted Polymers. Anal Bioanal Chem. 2015 Apr;407(10):2923-31.
    [参考文献]: Chuan-Wei Jang, Et Al. A Novel Selection Marker For Efficient Dna Cloning And Recombineering In E. Coli. Plos One. 2013;8(2):E57075.

    合成参考文献


    摘要:Journal of Pharmacology and Experimental Therapeutics., 84(184), 1945
    参考文献:10.1016/s0378-4347(00)81606-0
    摘要:Reece PA, Peikert M. Simple and selective high-performance liquid chromatographic method for estimating plasma quinidine levels. Journal of Chromatography B: Biomedical Sciences and Applications. 1980 Feb;181(2):207–17. doi: 10.1016/s0378-4347(00)81606-0.
    参考文献:10.1016/j.jacc.2003.12.046
    摘要:Hermida J, Denjoy I, Clerc J, Extramiana F, Jarry G, Milliez P, Guicheney P, Di Fusco S, Rey J, Cauchemez B, Leenhardt A. Hydroquinidine therapy in Brugada syndrome. Journal of the American College of Cardiology. 2004 May;43(10):1853–60. doi: 10.1016/j.jacc.2003.12.046.
    参考文献:10.1007/s00216-020-02866-4
    摘要:Zhang L, Wei Z, He S, Huang Y, Liu Z. Preparation, characterization, and application of soluble liquid crystalline molecularly imprinted polymer in electrochemical sensor. Analytical and Bioanalytical Chemistry. 2020 Aug 12;412(26):7321–32. doi: 10.1007/s00216-020-02866-4.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知